Back
DocuSign, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
54
DOCU
DocuSign, Inc.
Last Price:
$65.66
Seasonality Move:
12.2%
Buy
72
KYMR
Kymera Therapeutics, Inc.
Last Price:
$66.69
Seasonality Move:
7.7%
Buy
54
DocuSign, Inc. (DOCU)
is a Buy
Is DocuSign, Inc. a Buy, Sell or Hold?
-
The current DocuSign, Inc. [DOCU] share price is $65.67. The Score for DOCU is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
DOCU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $66.62. The Score for KYMR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DOCU Stock Price Chart
What is DocuSign, Inc.'s stock price today?
-
The DocuSign, Inc. share price today is $65.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DOCU is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $66.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DOCU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 41.52 | Sell |
| Chaikin Money Flow: | 2428374 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.97 - 70.93) | Sell |
| Bollinger Bands (100): | (67.83 - 78.89) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.78 | Buy |
| Relative Strength Index (14 RSI): | 60.29 | Buy |
| Chaikin Money Flow: | 254539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.36 - 66.56) | Buy |
| Bollinger Bands (100): | (43.77 - 61.91) | Buy |
DOCU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 68.85 | Sell |
| 20-day SMA: | 67.68 | Sell |
| 50-day SMA: | 69.74 | Sell |
| 200-day SMA: | 77.21 | Sell |
| 8-day EMA: | 68.35 | Sell |
| 20-day EMA: | 68.39 | Sell |
| 50-day EMA: | 70.22 | Sell |
| 200-day EMA: | 74.63 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.47 | Buy |
| 20-day SMA: | 64.83 | Buy |
| 50-day SMA: | 61.21 | Buy |
| 200-day SMA: | 43.96 | Buy |
| 8-day EMA: | 66.09 | Buy |
| 20-day EMA: | 64.75 | Buy |
| 50-day EMA: | 60.61 | Buy |
| 200-day EMA: | 48.97 | Buy |
DocuSign, Inc. Earnings Growth & DOCU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.24 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.
DocuSign, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||